BioPorto A/S (CPH:BIOPOR)
Denmark
· Delayed Price · Currency is DKK 1.450
+0.066 (4.77%)
Apr 1, 2025, 4:53 PM CET
BioPorto Revenue
In the year 2024, BioPorto had annual revenue of 36.24M DKK with 17.07% growth. BioPorto had revenue of 7.90M in the quarter ending December 31, 2024, with 20.38% growth.
Revenue
36.24M
Revenue Growth
+17.07%
P/S Ratio
15.49
Revenue / Employee
755.06K
Employees
48
Market Cap
594.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.24M | 5.29M | 17.07% |
| Dec 31, 2023 | 30.96M | 1.99M | 6.87% |
| Dec 31, 2022 | 28.97M | 4.72M | 19.44% |
| Dec 31, 2021 | 24.25M | 1.05M | 4.53% |
| Dec 31, 2020 | 23.20M | -3.42M | -12.84% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 290.40B |
| Coloplast | 27.45B |
| Genmab | 21.53B |
| Demant | 22.42B |
| Zealand Pharma | 62.69M |
| H. Lundbeck | 22.00B |
| Ambu A/S | 5.65B |
| ALK-Abelló | 5.54B |
BioPorto News
- 12 days ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 12 days ago - BioPorto announces the Annual Report for 2024 - GlobeNewsWire
- 13 days ago - BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029 - GlobeNewsWire
- 4 weeks ago - BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates - GlobeNewsWire
- 4 weeks ago - Strengthening of Investor Focus – BioPorto enters Market Maker Agreement with Danske Bank & appoints New Head of Investor Relations - GlobeNewsWire
- 2 months ago - BioPorto A/S appoints new interim Chairman of the Board - GlobeNewsWire
- 2 months ago - BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals - GlobeNewsWire
- 3 months ago - BioPorto commences process to appoint new Chair of the Board of Directors - GlobeNewsWire